Visscher H - Search Results

1

Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene.

Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR. Singaraja RR, et al. Among authors: visscher h. Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1322-32. doi: 10.1161/01.ATV.0000078520.89539.77. Epub 2003 May 22. Arterioscler Thromb Vasc Biol. 2003. PMID: 12763760 Review.

2

Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1.

Wellington CL, Brunham LR, Zhou S, Singaraja RR, Visscher H, Gelfer A, Ross C, James E, Liu G, Huber MT, Yang YZ, Parks RJ, Groen A, Fruchart-Najib J, Hayden MR. Wellington CL, et al. Among authors: visscher h. J Lipid Res. 2003 Aug;44(8):1470-80. doi: 10.1194/jlr.M300110-JLR200. Epub 2003 May 1. J Lipid Res. 2003. PMID: 12730295 Free article.

3

Alternate transcripts expressed in response to diet reflect tissue-specific regulation of ABCA1.

Singaraja RR, James ER, Crim J, Visscher H, Chatterjee A, Hayden MR. Singaraja RR, et al. Among authors: visscher h. J Lipid Res. 2005 Oct;46(10):2061-71. doi: 10.1194/jlr.M500133-JLR200. Epub 2005 Jul 16. J Lipid Res. 2005. PMID: 16024915 Free article.

4

Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro.

Singaraja RR, Visscher H, James ER, Chroni A, Coutinho JM, Brunham LR, Kang MH, Zannis VI, Chimini G, Hayden MR. Singaraja RR, et al. Among authors: visscher h. Circ Res. 2006 Aug 18;99(4):389-97. doi: 10.1161/01.RES.0000237920.70451.ad. Epub 2006 Jul 27. Circ Res. 2006. PMID: 16873719

5

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.

Visscher H, Ross CJ, Rassekh SR, Barhdadi A, Dubé MP, Al-Saloos H, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Brown AM, Rogers PC, Phillips MS, Rieder MJ, Carleton BC, Hayden MR; Canadian Pharmacogenomics Network for Drug Safety Consortium. Visscher H, et al. J Clin Oncol. 2012 May 1;30(13):1422-8. doi: 10.1200/JCO.2010.34.3467. Epub 2011 Sep 6. J Clin Oncol. 2012. PMID: 21900104

6

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Brunham LR, Lansberg PJ, Zhang L, Miao F, Carter C, Hovingh GK, Visscher H, Jukema JW, Stalenhoef AF, Ross CJ, Carleton BC, Kastelein JJ, Hayden MR. Brunham LR, et al. Among authors: visscher h. Pharmacogenomics J. 2012 Jun;12(3):233-7. doi: 10.1038/tpj.2010.92. Epub 2011 Jan 18. Pharmacogenomics J. 2012. PMID: 21243006

7

CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, Collins JA, Semaka A, Hudson TJ, Hayden MR. Warby SC, et al. Among authors: visscher h. Am J Hum Genet. 2009 Mar;84(3):351-66. doi: 10.1016/j.ajhg.2009.02.003. Epub 2009 Feb 26. Am J Hum Genet. 2009. PMID: 19249009 Free PMC article.

8

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.

Ross CJ, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT, Rieder MJ, Koren G, Carleton BC, Hayden MR; CPNDS Consortium. Ross CJ, et al. Among authors: visscher h. Thyroid. 2010 Jul;20(7):681-7. doi: 10.1089/thy.2010.1642. Thyroid. 2010. PMID: 20578893 Review.

9

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Aminkeng F, Ross CJ, Rassekh SR, Brunham LR, Sistonen J, Dube MP, Ibrahim M, Nyambo TB, Omar SA, Froment A, Bodo JM, Tishkoff S, Carleton BC, Hayden MR; Canadian Pharmacogenomics Network for Drug Safety Consortium. Aminkeng F, et al. Pharmacogenomics J. 2014 Apr;14(2):160-70. doi: 10.1038/tpj.2013.13. Epub 2013 Apr 16. Pharmacogenomics J. 2014. PMID: 23588107 Free PMC article.

10

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.

Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, Brunham LR, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Amstutz U, Rieder MJ, Bernstein D, Carleton BC, Hayden MR, Ross CJ; Canadian Pharmacogenomics Network for Drug Safety Consortium. Aminkeng F, et al. Among authors: visscher h. Nat Genet. 2015 Sep;47(9):1079-84. doi: 10.1038/ng.3374. Epub 2015 Aug 3. Nat Genet. 2015. PMID: 26237429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters